David Ford is an Oxford-based active life sciences angel investor, currently managing and advising an active portfolio of more than 20 companies, focused on AI-based drug design, the application of machine learning to systems biology and nanoparticle delivery technology, to name but a few. David is also a non-executive director on a listed venture capital trust and Alcentra, a specialist sub-investment grade debt fund management business. He has investments in Oxford, Cambridge and London, as well as belonging to angel networks across both Cambridge and Oxford.